Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chloe J Jordan

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 29, 2022
NPP's approach toward improving rigor and transparency in clinical trials researchSofiya Hupalo, Chloe J Jordan, Terri Bowen, et al.
Addiction Biology|February 4, 2021
Optogenetic brain-stimulation reward: A new procedure to re-evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter-Cre miceBree A Humburg, Chloe J Jordan, Hai-Ying Zhang, et al.
Molecular Psychiatry|January 22, 2022
Involvement of the ghrelin system in the maintenance of oxycodone self-administration: converging evidence from endocrine, pharmacologic and transgenic approachesZhi-Bing You, Eliot L Gardner, Ewa Galaj, et al.
Scientific Reports|March 1, 2018
mGluR5 antagonism inhibits cocaine reinforcement and relapse by elevation of extracellular glutamate in the nucleus accumbens via a CB1 receptor mechanismXia Li, Xiao-Qing Peng, Chloe J Jordan, et al.
Neuropharmacology|April 12, 2019
The highly selective dopamine D<sub>3</sub>R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodentsChloe J Jordan, Bree Humburg, Myra Rice, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 13, 2019
Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disordersAmy Hauck Newman, Jianjing Cao, Jacqueline D Keighron, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 28, 2020
Modafinil potentiates cocaine self-administration by a dopamine-independent mechanism: possible involvement of gap junctionsMaddalena Mereu, Takato Hiranita, Chloe J Jordan, et al.
Translational Psychiatry|November 9, 2021
Synaptic Zn<sup>2+</sup> potentiates the effects of cocaine on striatal dopamine neurotransmission and behaviorJuan L Gomez, Jordi Bonaventura, Jacqueline Keighron, et al.
Developmental Cognitive Neuroscience|August 4, 2024
The HEALthy Brain and Child Development Study (HBCD): NIH collaboration to understand the impacts of prenatal and early life experiences on brain developmentNora D Volkow, Joshua A Gordon, Diana W Bianchi, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 29, 2022
NPP's approach toward improving rigor and transparency in clinical trials researchSofiya Hupalo, Chloe J Jordan, Terri Bowen, et al.
Addiction Biology|February 4, 2021
Optogenetic brain-stimulation reward: A new procedure to re-evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter-Cre miceBree A Humburg, Chloe J Jordan, Hai-Ying Zhang, et al.
Molecular Psychiatry|January 22, 2022
Involvement of the ghrelin system in the maintenance of oxycodone self-administration: converging evidence from endocrine, pharmacologic and transgenic approachesZhi-Bing You, Eliot L Gardner, Ewa Galaj, et al.
Scientific Reports|March 1, 2018
mGluR5 antagonism inhibits cocaine reinforcement and relapse by elevation of extracellular glutamate in the nucleus accumbens via a CB1 receptor mechanismXia Li, Xiao-Qing Peng, Chloe J Jordan, et al.
Neuropharmacology|April 12, 2019
The highly selective dopamine D<sub>3</sub>R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodentsChloe J Jordan, Bree Humburg, Myra Rice, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 13, 2019
Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disordersAmy Hauck Newman, Jianjing Cao, Jacqueline D Keighron, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 28, 2020
Modafinil potentiates cocaine self-administration by a dopamine-independent mechanism: possible involvement of gap junctionsMaddalena Mereu, Takato Hiranita, Chloe J Jordan, et al.
Translational Psychiatry|November 9, 2021
Synaptic Zn<sup>2+</sup> potentiates the effects of cocaine on striatal dopamine neurotransmission and behaviorJuan L Gomez, Jordi Bonaventura, Jacqueline Keighron, et al.
Developmental Cognitive Neuroscience|August 4, 2024
The HEALthy Brain and Child Development Study (HBCD): NIH collaboration to understand the impacts of prenatal and early life experiences on brain developmentNora D Volkow, Joshua A Gordon, Diana W Bianchi, et al.
Pageof 5